Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

Treprostinil palmitil

Status:

Phase 2

Condition:

Pulmonary Hypertension

Intervention Type:

Inhaled Drug

Funder Type:

Industry

Drug Details

Treprostinil palmitil is an inhaled long-acting pulmonary vasodilator prodrug of treprostinil that has been formulated for delivery as a dry powder.

Study Purpose

The primary objective of this study is to evaluate the safety and tolerability of treprostinil palmitil inhalation powder (TPIP) compared with placebo.

Find a Clinical Trial